Patent · US Active

Methods and devices for the treatment of ocular diseases in human subjects

US9572800B2 · kind B2 · utility

22Cited by
144References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 31, 2016
Grant dateFeb 21, 2017
Priority date
Expiry dateMar 31, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2037/0061
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.